Business UroGen to raise $120m after positive bladder cancer trial results Nick J Adam Jul 30, 2023 UroGen Pharma (TASE: URGN), which develops uro-oncological treatments, last week published positive… Read More...
Health A wearable ultrasound scanner could detect breast cancer earlier: The new device, which can be… James Pereira Jul 30, 2023 When breast cancer is diagnosed in the earliest stages, the survival rate is nearly 100 percent. However, for tumors… Read More...
Health The Silent Killer: What Causes Prostate Cancer? James Pereira Jul 30, 2023 In 2023 alone, 288,300 new cases of prostate cancer will be diagnosed in the United States, according to the American… Read More...
Sports How a grueling cancer battle helped Chargers’ Brandon Staley in life and in football Amelia Podder Jul 30, 2023 The losses were dramatic, certainly, even historic, the Chargers’ last two seasons ending in ways difficult to… Read More...
Health Aravive to Present Updated Clinical Data from Batiraxcept Trials in Renal and Pancreatic Cancer at… James Pereira Jul 30, 2023 HOUSTON, July 28, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage… Read More...
Health Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites James Pereira Jul 30, 2023 Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX)… Read More...
Health IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of… James Pereira Jul 30, 2023 NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company… Read More...
Health Research points to potential new medical therapy for Lyme disease: Medication used to halt cancer… James Pereira Jul 30, 2023 A medical therapy that inhibits the growth of cancer cells may one day be effective at treating Lyme disease, according… Read More...
Health Couch Potatoes Take Note: Climb Some Stairs to Cut Cancer Risk James Pereira Jul 30, 2023 For… Read More...